52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B
Figure 1
Patient disposition.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Patient disposition.